Affluent Medical SA

EPA:AFME.PA

1.68 (EUR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 0.3310.3310.3170.3170.2950.2950.3170.3170.3530.3530.4280.4280.2980.2980.2340.2340.1790.179
Cost of Revenue 0.4590.4590.6240.4781.2060.5891.2190.5271.2310.8111.2440.6481.1760.7230.8420.8420.7880.788
Gross Profit -0.129-0.129-0.307-0.161-0.911-0.294-0.902-0.21-0.879-0.459-0.817-0.221-0.878-0.425-0.609-0.609-0.61-0.61
Gross Profit Ratio -0.389-0.389-0.967-0.506-3.088-0.995-2.845-0.662-2.492-1.301-1.91-0.516-2.946-1.424-2.606-2.606-3.415-3.415
Reseach & Development Expenses 000000000000000000
General & Administrative Expenses 007.4043.2126.8362.8176.3162.626.862.6135.3912.0255.8512.7922.1222.1221.9211.921
Selling & Marketing Expenses 000.0140.0260.0260.0260.0290.0290.0120.0120.0190.0190.0040.0040.0050.0050.0060.006
SG&A 3.7063.7063.0913.2376.8612.8426.3452.6496.8712.6255.412.0445.8542.7952.1262.1261.9271.927
Other Expenses 0.5690.569-0.0480-0.0490-0.03900.0730-0.12100.25600000
Operating Expenses 4.2754.2753.7093.8516.913.3976.3843.2656.7983.2355.5312.7195.5982.7472.6342.6342.3472.347
Operating Income -4.404-4.404-3.987-3.987-8.116-3.713-7.603-3.477-8.029-3.718-6.775-2.92-6.774-3.756-3.265-3.265-2.97-2.97
Operating Income Ratio -13.324-13.324-12.576-12.576-27.512-12.585-23.984-10.967-22.777-10.548-15.848-6.829-22.732-12.604-13.983-13.983-16.636-16.636
Total Other Income Expenses Net -0.319-0.3190.1140.114-0.524-0.317-0.149-0.085-0.944-0.42-1.516-0.835-1.279-0.101-0.416-0.416-0.614-0.614
Income Before Tax -4.723-4.723-3.873-3.873-8.64-4.029-7.752-3.562-8.973-4.138-8.291-3.772-8.053-3.857-3.681-3.681-3.584-3.584
Income Before Tax Ratio -14.289-14.289-12.216-12.216-29.288-13.658-24.454-11.235-25.455-11.74-19.394-8.823-27.023-12.941-15.762-15.762-20.076-20.076
Income Tax Expense -0.7260.0390.0360.036-0.660.039-0.7170.044-0.7810.043-1.0810.167-0.4570.0520.0470.0470.0580.058
Net Income -4.684-4.684-3.837-3.837-7.98-3.99-7.035-3.518-8.192-4.096-7.21-3.605-7.61-3.805-3.634-3.634-3.526-3.526
Net Income Ratio -14.172-14.172-12.103-12.103-27.051-13.525-22.192-11.096-23.24-11.62-16.865-8.433-25.537-12.768-15.561-15.561-19.754-19.754
EPS -0.29-0.148-0.13-0.13-0.29-0.15-0.36-0.18-0.44-0.23-0.39-0.2-0.41-0.24-0.25-0.25-0.29-0.29
EPS Diluted -0.29-0.147-0.12-0.13-0.29-0.15-0.36-0.18-0.44-0.23-0.39-0.2-0.41-0.24-0.25-0.25-0.29-0.29
EBITDA -3.803-3.803-3.473-3.294-6.748-3.199-6.384-2.97-6.842-3.196-5.373-2.4-5.496-3.229-2.958-2.958-2.453-2.453
EBITDA Ratio -11.505-11.505-10.954-10.39-23.424-10.844-20.139-9.368-19.285-9.067-12.938-5.613-18.785-10.836-12.666-12.666-13.739-13.739